The role of mTOR signaling in Alzheimer disease
Frontiers in Bioscience · 2012 · S4 (3) · 941-952
DOI: 10.2741/s310 ↗At a glance
Übersichtsarbeit in Frontiers in Bioscience, 2012. Written by Salvatore Oddo. Institution: Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. oddo@uthscsa.edu. Cited 211 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIA NIH HHS.
Topics: Demenz
Abstract (original language)
The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of rapamycin (mTOR) may play a role in Abeta and tau induced neurodegeneration.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. oddo@uthscsa.edu
Funding
- NIA NIH HHS
Cite
APA
Oddo, S. (2012). The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience, S4(3), 941-952. https://doi.org/10.2741/s310
Vancouver
Oddo S. The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience. 2012;S4(3):941-952. doi:10.2741/s310
BibTeX
@article{Oddo2012,
author = {Oddo, Salvatore},
title = {The role of mTOR signaling in Alzheimer disease},
journal = {Frontiers in Bioscience},
year = {2012},
volume = {S4},
number = {3},
pages = {941--952},
doi = {10.2741/s310}
}
EUVIMED